We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RF:EURONEXT PARISEurazeo SE Analysis

Data as of 2026-03-16 - not real-time

$25.33

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Regions Financial is trading at $25.33, well below its DCF‑derived fair value of $45.20, implying an upside of roughly 22 %. The stock’s forward PE of 8.9 and trailing PE of 11 are comfortably under the industry average of 16.5, positioning it as a clear value play. Revenue growth of 15.6 % and an ROE of 11.7 % support the earnings outlook, while a dividend yield of 4.18 % with a payout ratio under 45 % signals a sustainable income stream. Technical metrics show the price sitting beneath the 20‑day (27.84) and 50‑day (28.46) SMAs, with a low RSI of 28 indicating oversold conditions, yet the MACD remains bearish. Support sits at $24.92 and resistance at $30.30, framing a near‑term range.
The volatility of 31.6 % and a beta of 1.10 suggest higher than market risk, but the company’s zero‑debt balance sheet and stable volume mitigate liquidity concerns. Given the material news of recent dividend declarations and by‑law changes enhancing shareholder rights, the fundamentals remain robust. The combination of a sizable valuation gap, solid dividend profile, and improving earnings momentum justifies a bullish stance for the medium to long term, while short‑term caution is advised due to bearish momentum signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI at 28 suggests oversold condition
  • Price below key moving averages
  • Proximity to support level at $24.92

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation upside of ~22 % to target median $30.15
  • Sustainable dividend yield of 4.18 %
  • Revenue growth of 15.6 % and strong ROE

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value indicating $45.20 price target
  • Zero‑debt balance sheet reducing financial risk
  • Consistent earnings and dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth15.60%
Profit Margin30.56%
P/E Ratio11.0
ROE11.65%
ROA1.36%
P/B Ratio1.2
Op. Cash Flow$2.2B
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI28.5
Support$24.92
Resistance$30.30
MA 20$27.84
MA 50$28.46
MA 200$26.03
MACDBearish
VolumeStable
Fear & Greed Index79.45

Valuation

Fair Value$45.20
Target Price$30.90
Upside/Downside21.99%
GradeUndervalued
TypeValue
Dividend Yield4.18%

Risk Assessment

Beta1.10
Volatility31.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.